Literature DB >> 7039195

Amiodarone versus quinidine in the prophylaxis of atrial fibrillation.

E Vitolo, M Tronci, M T Larovere, R Rumolo, A Morabito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7039195

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN： 0001-5385            Impact factor:   1.718


× No keyword cloud information.
  10 in total

1.  Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?

Authors:  Dariusz A Kosior; Marcin Szulc; Grzegorz Opolski; Adam Torbicki; Daniel Rabczenko
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

Review 2.  Cardioversion of atrial fibrillation.

Authors:  G Y Lip
Journal:  Postgrad Med J       Date:  1995-08       Impact factor: 2.401

3.  Atrial fibrillation and embolism.

Authors:  J A Milliken
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

Review 4.  Amiodarone in long term prophylaxis.

Authors:  D Katritsis; A J Camm
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 5.  A benefit-risk assessment of class III antiarrhythmic agents.

Authors:  Bente Brendorp; Oledyg Pedersen; Christian Torp-Pedersen; Naji Sahebzadah; Lars Køber
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 6.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

Review 7.  New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.

Authors:  Stanley Nattel; Paul Khairy; Denis Roy; Bernard Thibault; Peter Guerra; Mario Talajic; Marc Dubuc
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 8.  Treatment of nonvalvular atrial fibrillation.

Authors:  G D Stettin
Journal:  West J Med       Date:  1995-04

Review 9.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

10.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Authors:  Lucie Valembois; Etienne Audureau; Andrea Takeda; Witold Jarzebowski; Joël Belmin; Carmelo Lafuente-Lafuente
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.